SCHEMBL1089317

SCHEMBL1089317

O=C(O)COc1ccccc1CN1CCC(Nc2nccc(N3CCCCCC3)n2)C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.68
ROCK2 O75116 1/20 0.41
HRH4 Q9H3N8 4/20 0.41
ACHE P22303 3/20 0.40
TBXAS1 P24557 2/20 0.40
BACE1 P56817 2/20 0.39
EHMT2 Q96KQ7 1/20 0.39
JUN P05412 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK8 P45983 1/20 0.39
MAPK9 P45984 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HRH2 P25021 1/20 0.39
CYP3A4 P08684 1/20 0.38
CCNK O75909 1/20 0.38
CDK12 Q9NYV4 1/20 0.38
SYK P43405 1/20 0.38
IGF1R P08069 1/20 0.38
ALK Q9UM73 1/20 0.38
CCNC P24863 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089357 0.96 CXCR4 (0.61) CXCR4ROCK2HRH4TBXAS1EHMT2
SCHEMBL1089422 0.95 CXCR4 (0.59) CXCR4HRH4ACHETBXAS1BACE1
SCHEMBL1091515 0.94 CXCR4 (0.58) CXCR4ROCK2HRH4TBXAS1MAPK8
SCHEMBL1089790 0.88 CXCR4 (0.76) CXCR4HRH4ACHEBACE1EHMT2
SCHEMBL1089124 0.87 CXCR4 (0.71) CXCR4ROCK2HRH4ACHEBACE1
SCHEMBL1089182 0.84 CXCR4 (0.74) CXCR4ROCK2HRH4ACHEBACE1
SCHEMBL1089515 0.83 CXCR4 (0.69) CXCR4ROCK2HRH4ACHEBACE1
SCHEMBL1088089 0.82 CXCR4 (0.64) CXCR4ROCK2HRH4EHMT2KDM4E
SCHEMBL1090142 0.82 CXCR4 (0.67) CXCR4HRH4ACHEBACE1EHMT2
SCHEMBL9972356 0.81 CXCR4 (0.58) CXCR4ROCK2HRH4EHMT2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ROCK2 4071/4885HRH4 130/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885ROCK2 4071/4885HRH4 130/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ROCK2 4071/4885HRH4 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.